Determining the best dose of lithium carbonate as adjuvant therapy to radioactive iodine for the treatment of hyperthyroidism: a systematic review and meta-analysis [0.03%]
碳酸锂的最佳剂量作为放射性碘治疗甲状腺功能亢进症的辅助疗法：系统评价和meta分析
Mohamed Abd-ElGawad,Mahmoud Shaaban Abdelgalil,Manar Mabrouk et al.
Mohamed Abd-ElGawad et al.
Background: Hyperthyroidism poses challenges, and common treatments like Radioactive Iodine (RAI) have limitations, prompting exploration of adjunctive approaches. This meta-analysis evaluates the combined impact of RAI a...
Nocturnal enuresis associated with lithium carbonate extended-release tablets in a girl with major depressive disorder: A case report [0.03%]
一例锂碳酸盐缓释片所致夜间遗尿症的少女抑郁症患者病例报告
Yanping Feng,Qingqing Xiang,Xianzhen Dai et al.
Yanping Feng et al.
Rationale: Lithium carbonate, a mood stabilizer, is most commonly used for the treatment and prevention of mania and bipolar disorder. Common renal side effects include polyuria and polydipsia. However, when combined with...
Case Reports
Medicine. 2025 May 16;104(20):e42505. DOI:10.1097/MD.0000000000042505 2025
Acetazolamide as an aquaporin 1 inhibitor mitigates rheumatoid arthritis by reducing angiogenesis via the modulation of the FAK-PI3K/Akt signaling pathway [0.03%]
通过调节FAK-PI3K/Akt信号通路减少血管生成从而缓解类风湿性关节炎的碳酸锂类似物乙酰唑胺（ACZ）的作用及机制研究
Man-Yu Zhang,Meng-Yuan Zhou,Xue-Na Gong et al.
Man-Yu Zhang et al.
Synovial angiogenesis worsens the course of rheumatoid arthritis (RA) by driving pannus formation and chronic inflammation, implying anti-angiogenesis as a possible treatment strategy. Aquaporin 1 (AQP1) is a promising target for RA, and it...
Comparative efficacy and safety of alternatives to sodium valproate in the management of bipolar affective disorder in people of child-bearing age: a narrative review by the European Society of Clinical Pharmacy's mental health specialist interest group [0.03%]
欧洲临床药学会精神健康专家兴趣小组对育龄人群双相情感障碍替代碳酸锂治疗有效性和安全性的叙述性回顾
Ita Fitzgerald,Izgi Bayraktar,Birgit Eiden et al.
Ita Fitzgerald et al.
Background: The European Medicines Agency has recommended a series of restrictions on the use of sodium valproate (valproate) following research linking its exposure in utero to adverse congenital and neurodevelopmental e...
Lithium carbonate exposure disrupts neurodevelopment by perturbing primary cilia and ER homeostasis [0.03%]
碳酸锂通过扰乱初级纤毛和内质网稳态来干扰神经发育
Zhen Guan,Yingchao Liang,Zhiqiang Zhu et al.
Zhen Guan et al.
Lithium, which is widely used in medicine and batteries, has become increasingly prevalent in the environment, raising concerns about its impact on human health. Lithium carbonate (Li2CO3) is a common treatment and relapse prevention method...
From Li2CO3 to Li2C2O4: Understanding Discharge Product Decomposition in Li-CO2 Batteries [0.03%]
从Li2CO3到Li2C2O4：了解Li-CO2电池放电产物分解过程
Lixin Xiong,Neil Qiang Su
Lixin Xiong
Rechargeable lithium-carbon dioxide (Li-CO2) batteries are promising for CO2 capture and energy storage. However, the high decomposition potential and sluggish kinetics of the discharge product Li2CO3 limit their practical development. Rece...
The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat [0.03%]
情绪稳定剂碳酸锂和丙戊酸盐干扰肝脏和肠道法尼醇X受体信号并增加大鼠胆汁合成
Sofia Cussotto,Anna V Golubeva,Alvaro Lopez Gallardo et al.
Sofia Cussotto et al.
The mood stabilizers lithium and valproate are psychotropic medications widely used in clinical practice. Despite their proven benefits, many individuals stop their treatment due to the adverse effects. Chronic diarrhoea is a common reason ...
Current and Future Impacts of Lithium Carbonate from Brines: A Global Regionalized Life Cycle Assessment Model [0.03%]
全球盐湖碳酸锂的现状及未来影响评估：一个区域生命周期评价模型
Vanessa Schenker,Stephan Pfister
Vanessa Schenker
Lithium (Li) is essential for decarbonization strategies, such as electric vehicles and renewable energy storage, which experiences the largest growth rates among metals required for low-carbon technologies. To meet this demand, the raw mat...
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK [0.03%]
利培酮增强治疗相对于碳酸锂增强治疗难治性抑郁症的临床效果和成本效益：在英国进行的一项实用、开放标签、平行组、随机对照优越性试验
Anthony J Cleare,Jess Kerr-Gaffney,Kimberley Goldsmith et al.
Anthony J Cleare et al.
Background: Lithium and quetiapine are first-line augmentation options for treatment-resistant depression; however, few studies have compared them directly, and none for longer than 8 weeks. We aimed to assess whether que...
Randomized Controlled Trial
The lancet. Psychiatry. 2025 Apr;12(4):276-288. DOI:10.1016/S2215-0366(25)00028-8 2025
High performance of 5 V LiNi0.5Mn1.5O4 cathode materials synthesized from recycled Li2CO3 for sustainable Lithium-Ion batteries [0.03%]
从回收的Li2CO3合成的5V LiNi0.5Mn1.5O4正极材料在可持续锂离子电池中的高性能表现
Yi-De Tsai,Ching-Hsiang Hsu,Jia-Hao Hu et al.
Yi-De Tsai et al.
Lithium has become a critical element in the modern era due to the emergence of lithium-ion battery (LIB) technologies as a mean to lessen the environmental burden created by the energy usage from conventional sources. In this study, Li2CO3...
耗时 0.10526 秒，为您在
48206918
条记录里面共找到 1234 篇文章 [XML]